Utility of blasts with a clear halo around the nucleolus as a predictive indicator for disease progression in patients with myelodysplastic syndromesand aplastic anemia
I. Emura et al., Utility of blasts with a clear halo around the nucleolus as a predictive indicator for disease progression in patients with myelodysplastic syndromesand aplastic anemia, DIAGN CYTOP, 22(5), 2000, pp. 275-280
This study was designed to evaluate the utility of blasts with a clear halo
around their nucleoli (BCHN) as a predictive indicator of disease progress
ion in myelodysplastic syndromes (MDSs) and aplastic anemia (AA). Bone marr
ow aspirates from 75 patients with MDSs and 18 with AA were fixed in 95% et
hanol solution or 10% neutral formalin and stained with the Papanicolaou me
thod. BCHNs were detected in 57 of 75 patients with MDSs and in 10 of 18 AA
patients Disease progression was restrictedly observed in 17 patients with
MDSs who had BCHNs at onset and in I patient with AA. The proportion of BC
HNs increased with disease progression in these 16 of 17 patients with MDSs
. The presence of BCHNs at onset and the increase in proportion of BCHNs du
ring the clinical course of MDSs were significant indications Sor predictin
g disease progression. Diagn. Cytopathol. 2000;22:275-280. (C) 2000 Wiley-L
iss, Inc.